Keyphrases
A172
31%
Anti-inflammatory Effect
29%
Anti-neuroinflammation
39%
Astrocytes
22%
Astroglia
26%
Astroglial Cells
50%
C57BL
24%
Central Nervous System
21%
Chemokine (C-C motif) Ligand 2 (CCL2)
41%
Chemokine Expression
41%
Chemokines
23%
Colon Adenocarcinoma
27%
CXCL10
96%
Cytotoxicity
22%
Dorsal Vagal Complex
21%
Ethanol
42%
Hippocampus
22%
HT-29
27%
Human Astrocytes
34%
Inducible Nitric Oxide Synthase
55%
Inflammation
40%
Inflammatory Chemokines
21%
Inflammatory Pathways
45%
Interleukin-1β
49%
Interleukin-6
29%
Lipopolysaccharide
60%
Lipopolysaccharide-induced
97%
Liver
30%
Metabolic Hormones
25%
Microglial Cells
21%
Monocyte Chemoattractant protein-1 (MCP-1)
22%
Morphine
20%
Neuroimmune Response
26%
Neuroimmune Signaling
28%
Neuroinflammation
81%
NF-B
50%
Nuclear factor-B
23%
Obesity
24%
Opioid Antagonist
33%
Ovariectomy
37%
OVX Rats
23%
Paraventricular nucleus
22%
Selenite
38%
Sex-specific
20%
Sickness
21%
Sickness Behavior
24%
Social Defeat
27%
Toll-like
51%
Weight Gain
34%
μ-opioid Receptor
20%
Neuroscience
Adeno-Associated Virus
18%
Alternative Complement Pathway C3 C5 Convertase
14%
Alzheimer's Disease
12%
Anti-Inflammatory
36%
Anxiety Disorder
11%
Arcuate Nucleus
25%
Astrocyte
77%
Behavior (Neuroscience)
44%
Blood Plasma
40%
CCL2
32%
Central Nervous System
26%
Cerebellum
16%
Chemokine
52%
CREB
18%
CXCL10
76%
Dentate Gyrus
18%
Duragesic
13%
Fentanyl
13%
Gamma Interferon Inducible Protein 10
26%
Ghrelin
13%
Glial Fibrillary Acidic Protein
17%
Hippocampus
33%
Human Immunodeficiency Virus
15%
In Vitro
11%
In Vivo
15%
Inducible Nitric Oxide Synthase
27%
Interferon
16%
Interleukin 1
32%
Interleukin 6
24%
Leptin
24%
Lipopolysaccharide
100%
Messenger RNA
12%
Microglia
36%
Monocyte Chemotactic Protein 1
13%
Mood Disorder
14%
Morphine
20%
Naltrexone
18%
Narcotic Antagonist
32%
Neurological Disorder
12%
Nitric Oxide Synthase
18%
Nuclear Factor
14%
Opiate
18%
Pervasive Developmental Disorder
11%
Proinflammatory Cytokine
13%
Protein Expression
17%
Receptor
13%
Sickness Behavior
18%
Social Defeat
27%
TLR 4
42%
μ-Opioid Receptor
26%
Pharmacology, Toxicology and Pharmaceutical Science
Alternative Complement Pathway C3 C5 Convertase
15%
Anti-Inflammatory Drug
19%
Antiinflammatory Activity
26%
Antiinflammatory Agent
10%
Aurintricarboxylic Acid
12%
Chemokine
70%
Colon Carcinoma
27%
Cytokine
29%
Cytotoxicity
18%
Disease
58%
Duragesic
15%
Enzyme-Linked Immunosorbent Assay
14%
Gamma Interferon Inducible Protein 10
14%
Glial Fibrillary Acidic Protein
12%
Glutathione
11%
Immunoglobulin Enhancer Binding Protein
17%
Inducible Nitric Oxide Synthase
27%
Inflammation
39%
Interferon
16%
Interleukin 1
20%
Interleukin 6
22%
Leptin
18%
Lipopolysaccharide
70%
Lipopolysaccharide-Induced Inflammation
27%
Lipopolysaccharide-Induced Neuroinflammation
15%
Microtus
10%
Microtus Ochrogaster
13%
Mitogen Activated Protein Kinase P38
9%
Mood Disorder
10%
Morphine
11%
Mu Opiate Receptor Antagonist
13%
Naltrexone
18%
Narcotic Antagonist
23%
Nervous System Inflammation
43%
Neurologic Disease
14%
Neuropathic Pain
13%
Nicotinic Receptor
19%
Nitric Oxide Synthase
9%
Normal Human
13%
Nuclear Factor
17%
Opiate
14%
Positive Allosteric Modulator
27%
Reactive Oxygen Metabolite
15%
Receptor
20%
Sodium Selenite
9%
Superoxide
14%
Toll Like Receptor 4
47%
Tumor Necrosis Factor
33%
Western Blot
10%
μ-Opioid Receptor
13%